Landscape of vaccine access and health technology assessment role in decision-making process in ASEAN countries

Over the past few years, many innovative vaccines became available that offer protection for diseases which have never been prevented before. While there are several factors that could have an impact on access, the use of health technology assessment (HTA) undoubtedly is also one of the contributing factors. Objectives: To explore the landscape of vaccine access and the role of HTA in new vaccine adoption in Association of Southeast Asian Nations (ASEAN) countries. Results: A great deal of progress has been made in terms of access to new and innovation vaccine in the region. Variation in access to these vaccines comparing between countries, however, is still observed. The use of HTA in supporting new vaccine adoption is still in an early stage especially in Gavi, the Vaccine Alliance-eligible countries. Conclusions: Improving the use of HTA evidences to support decision making could accelerate the efficient adoption of new vaccine in ASEAN region.

Medienart:

E-Artikel

Erscheinungsjahr:

2020

Erschienen:

2020

Enthalten in:

Zur Gesamtaufnahme - volume:16

Enthalten in:

Human vaccines & immunotherapeutics - 16(2020), 7 vom: 02. Juli, Seite 1728-1737

Sprache:

Englisch

Beteiligte Personen:

Taychakhoonavudh, Suthira [VerfasserIn]
Chumchujan, Woralak [VerfasserIn]
Hutubessy, Raymond [VerfasserIn]
Chaiyakunapruk, Nathorn [VerfasserIn]

Links:

Volltext

Themen:

ASEAN
Access
Expanded program in immunization
Health technology assessment
Journal Article
National immunization program
Vaccine
Vaccines

Anmerkungen:

Date Completed 21.06.2021

Date Revised 24.06.2021

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1080/21645515.2020.1769388

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM311526225